Group B Streptococcus in pregnancy
Streptococcus agalactiae — maternal genital/rectal coloniser
Overview
GBS colonises the vagina/rectum of ~20–25% of women and is the leading cause of EARLY-ONSET neonatal sepsis. The UK uses a RISK-BASED intrapartum antibiotic prophylaxis (IAP) strategy — it does NOT offer universal antenatal screening (unlike the USA).
Recognise
- Usually asymptomatic maternal colonisation (often an incidental swab/urine finding)
- Risk of vertical transmission in labour → early-onset neonatal GBS sepsis/pneumonia/meningitis (<7 days)
- GBS bacteriuria in pregnancy = heavier colonisation → treat + IAP in labour
Red flags
- Preterm labour, intrapartum pyrexia ≥38°C / suspected chorioamnionitis, prolonged rupture of membranes, or a previous baby with GBS disease → offer IAP
Differentials & how to tell them apart
Investigations
No universal screening in the UK. GBS found incidentally on a vaginal/rectal swab or in urine. Decision to give IAP is based on RISK FACTORS, not a screening result.
Management
Intrapartum IV benzylpenicillin as soon as labour starts (risk-based IAP)
- 1Offer intrapartum antibiotic prophylaxis (IV benzylpenicillin) to women with risk factors: previous infant with GBS disease, GBS in this pregnancy, preterm labour, pyrexia ≥38°C, or prolonged ROM.Gate: Penicillin allergy → cefuroxime; severe allergy/anaphylaxis → vancomycin
- 2Suspected chorioamnionitis → broad-spectrum IV antibiotics AND expedite delivery (IAP alone is not enough).
- 3Previous baby affected → IAP regardless of swab status (and discuss in this pregnancy).
Key points
The exam contrast: the UK is RISK-BASED (no routine screening); the US screens universally at 35–37 weeks. IAP prevents EARLY-onset (not late-onset) neonatal GBS disease.
Monitor & prognosis
Observe the neonate per the early-onset sepsis pathway if risk factors/inadequate IAP.
IAP markedly reduces early-onset neonatal GBS sepsis.
Source: RCOG Green-top Guideline 36 (GBS in pregnancy)